Elabscience
SKU:E-AB-66554
TPI1 Polyclonal Antibody
TPI1 Polyclonal Antibody
Couldn't load pickup availability
TPI1 Polyclonal Antibody
The TPI1 Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and quantification of triosephosphate isomerase 1 (TPI1) protein. This antibody is produced using advanced recombinant DNA technology, ensuring high purity and batch-to-batch consistency.
Triosephosphate isomerase 1 is a key enzyme involved in the glycolytic pathway, playing a crucial role in energy metabolism. Dysregulation of TPI1 has been implicated in various pathological conditions, including cancer, metabolic disorders, and neurodegenerative diseases. Therefore, accurate measurement of TPI1 protein levels is of utmost importance in both research and clinical settings.
The TPI1 Polyclonal Antibody exhibits exceptional specificity, binding exclusively to the TPI1 protein without cross-reactivity to other related proteins. This antibody has been extensively validated using various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence, ensuring reliable and reproducible results.
With its high sensitivity, the TPI1 Polyclonal Antibody allows for the detection of low-abundance TPI1 protein in complex biological samples. Its robust performance enables accurate quantification of TPI1 protein levels, facilitating comprehensive investigations into its functional role and potential therapeutic targeting.
The TPI1 Polyclonal Antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming antibody preparation. It is available in various sizes to accommodate different experimental requirements. Each batch is subjected to rigorous quality control measures to ensure optimal performance and consistency.
In summary, the TPI1 Polyclonal Antibody is a reliable and versatile tool for the detection and quantification of TPI1 protein. Its high specificity, sensitivity, and ease of use make it an invaluable asset for researchers and clinicians studying TPI1-related diseases and exploring potential therapeutic interventions.
Share
